The drugs regulator of the European Union (EU) approved on Oct. 25 the COVID-19 booster shot developed by Moderna.
The European Medicines Agency (EMA) said that the Moderna COVID-19 booster dose “may be considered” in people aged 18 years and older.
EMA said the decision was based on data that shows that a third dose given at least six months after the second dose led to an increase in antibodies that protect against the virus.
EMA also said that the booster dose contains half the dose used for the primary series and has similar side effects to those after the second dose.
It is up to national public health bodies in Europe to issue official recommendations to use the booster shot.
The Moderna COVID-19 booster shot is the second to be approved in the EU, with the Pfizer-BioNTech COVID-19 booster dose being the first.
© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.